药监协议:谈判安全数据交换时间表:同意不同意? 这就是问题
Wendy Manko Singer1, Elizabeth MacEntee Pileggi2, Yvonne Gibble3
1Individual Case Medical Review, Global Clinical Safety & Pharmacovigilance, Merck, Sharp & Dohme, LLC, Rahway, NJ, USA. wendy.manko.singer@merck.com.
Therapeutic innovation & regulatory science
|June 21, 2023
概括
制药合作伙伴关系包括安全数据交换协议. 一项调查揭示了共同的数据类型和时间表,突出了通过积极的协议开发和技术整合来提高效率和患者安全的机会.
科学领域:
- 药物监督 药物监督 药物监督
- 监管科学 监管科学
- 合同管理 合同管理
背景情况:
- 制药公司通过药物开发和市场准入的合同进行合作.
- 这些协议要求交换安全数据,以满足监管报告和确保患者安全.
研究的目的:
- 进行第一个关于制药行业安全数据交换协议的比较调查.
- 分析常见的安全数据类型和交换时间表.
- 确定改善谈判和程序效率的领域.
主要方法:
- 向制药公司分发了一份关于其安全数据交换合同的调查.
- 分析了来自378份合同的数据,包括临床试验和营销后来源.
- 评估了临床试验和营销后个人病例安全报告 (ICSR) 时间表的变化.
主要成果:
- 在临床试验ICSR时间表中,与营销后ICSR相比,观察到的变异性较小,这表明对试验的监管协调.
- 基准测试数据揭示了安全数据交换协议的挑战和复杂性.
- 该调查确定了共同的安全数据类型和交换时间表.
结论:
- 安全数据交换协议是复杂的,有机会提高效率.
- 积极的协议开发和技术采用可以改善流程和患者安全.
- 需要进一步的研究,以促进透明度和探索替代方法.
更多相关视频
相关概念视频
Pharmacovigilance
914
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
914
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Drug Control Governance: Regulatory Bodies and Their Impact
195
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
195
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Drug Administration and Therapy Phases: Overview
562
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
562


